Literature DB >> 22281375

"PancPro" as a tool for selecting families eligible for pancreatic cancer screening: an Italian study of incident cases.

Giulia Leonardi1, Santino Marchi, Massimo Falconi, Alessandro Zerbi, Valeria Ussia, Nicola de Bortoli, Franco Mosca, Silvano Presciuttini, Marco Del Chiaro.   

Abstract

BACKGROUND: PancPRO is a computer program that estimates the risk of pancreatic cancer for asymptomatic individuals based on a genetic model of susceptibility and the familial incidence of cancer. AIM: To evaluate the distribution of the familial risk in a series of incident cases of pancreatic adenocarcinoma.
MATERIALS AND METHODS: The lifetime risk of pancreatic cancer was calculated by PancPro for a hypothetical 40-year-old son of 570 consecutive probands with pancreatic cancer.
RESULTS: The 570 risk values were included between 1% and 13%. The distribution was bimodal, with the antimode located at risk=7.5%. Considering a 10-fold risk over the general population as a threshold for including a subject in a surveillance program, 19 families (3.3%) would be selected, totalling 92 first-degree relatives with age >40 years.
CONCLUSIONS: PancPro is a valid instrument to rank families based on risk of pancreatic cancer.
Copyright © 2011 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22281375     DOI: 10.1016/j.dld.2011.12.019

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  10 in total

Review 1.  Familial pancreatic cancer--current knowledge.

Authors:  Detlef K Bartsch; Thomas M Gress; Peter Langer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-06-05       Impact factor: 46.802

Review 2.  Genetic predisposition to pancreatic cancer.

Authors:  Paola Ghiorzo
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 3.  Familial pancreatic cancer--status quo.

Authors:  Volker Fendrich; Peter Langer; Detlef K Bartsch
Journal:  Int J Colorectal Dis       Date:  2013-08-16       Impact factor: 2.571

Review 4.  Screening for Pancreatic Cancer.

Authors:  Saowanee Ngamruengphong; Marcia Irene Canto
Journal:  Surg Clin North Am       Date:  2016-12       Impact factor: 2.741

Review 5.  High-risk population in sporadic pancreatic adenocarcinoma: guidelines for screening.

Authors:  Elizabeth H Bruenderman; Robert C G Martin
Journal:  J Surg Res       Date:  2014-10-13       Impact factor: 2.192

6.  Methods and outcomes of screening for pancreatic adenocarcinoma in high-risk individuals.

Authors:  Gabriele Capurso; Marianna Signoretti; Roberto Valente; Urban Arnelo; Matthias Lohr; Jan-Werner Poley; Gianfranco Delle Fave; Marco Del Chiaro
Journal:  World J Gastrointest Endosc       Date:  2015-07-25

7.  Development of a high risk pancreatic screening clinic using 3.0 T MRI.

Authors:  Chad A Barnes; Elizabeth Krzywda; Shannon Lahiff; Dena McDowell; Kathleen K Christians; Paul Knechtges; Parag Tolat; Mark Hohenwalter; Kulwinder Dua; Abdul H Khan; Douglas B Evans; Jennifer Geurts; Susan Tsai
Journal:  Fam Cancer       Date:  2018-01       Impact factor: 2.375

Review 8.  The genetics of ductal adenocarcinoma of the pancreas in the year 2020: dramatic progress, but far to go.

Authors:  Elizabeth D Thompson; Nicholas J Roberts; Laura D Wood; James R Eshleman; Michael G Goggins; Scott E Kern; Alison P Klein; Ralph H Hruban
Journal:  Mod Pathol       Date:  2020-07-23       Impact factor: 7.842

Review 9.  Familial pancreatic cancer: Concept, management and issues.

Authors:  Hiroyuki Matsubayashi; Kyoichi Takaori; Chigusa Morizane; Hiroyuki Maguchi; Masamichi Mizuma; Hideaki Takahashi; Keita Wada; Hiroko Hosoi; Shinichi Yachida; Masami Suzuki; Risa Usui; Toru Furukawa; Junji Furuse; Takamitsu Sato; Makoto Ueno; Yoshimi Kiyozumi; Susumu Hijioka; Nobumasa Mizuno; Takeshi Terashima; Masaki Mizumoto; Yuzo Kodama; Masako Torishima; Takahisa Kawaguchi; Reiko Ashida; Masayuki Kitano; Keiji Hanada; Masayuki Furukawa; Ken Kawabe; Yoshiyuki Majima; Toru Shimosegawa
Journal:  World J Gastroenterol       Date:  2017-02-14       Impact factor: 5.742

10.  Genetic counselling and personalised risk assessment in the Australian pancreatic cancer screening program.

Authors:  Tanya Dwarte; Skye McKay; Amber Johns; Katherine Tucker; Allan D Spigelman; David Williams; Alina Stoita
Journal:  Hered Cancer Clin Pract       Date:  2019-10-23       Impact factor: 2.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.